
Scoop: Lumos Labs has FDA nod for ADHD DtX Prismira
Lumos Labs has secured its first 510(k) clearance for a digital therapeutics offering, paving the way for entrance into the regulated app market.
Newsletters and Deep Dive digital magazine
Lumos Labs has secured its first 510(k) clearance for a digital therapeutics offering, paving the way for entrance into the regulated app market.
In the world of pharma-adjacent industries like research and manufacturing, the news in July was thick and fast.
It seems cardiologists are more optimistic than patients about the potential of AI in helping cardiac teams improve care and save lives.
A study of nearly 20,000 adults with self-reported ADHD diagnoses shows app-based games can improve scores on a battery of cognitive tests.
Editor's Picks
Newsletters and Deep Dive
digital magazine